DexCom Inc. (DXCM)
NASDAQ: DXCM
· Real-Time Price · USD
80.04
-0.97 (-1.20%)
At close: Jun 20, 2025, 3:59 PM
80.00
-0.05%
After-hours: Jun 20, 2025, 05:45 PM EDT
-1.20% (1D)
| Bid | 79.8 |
| Market Cap | 31.38B |
| Revenue (ttm) | 4.15B |
| Net Income (ttm) | 535.2M |
| EPS (ttm) | 1.33 |
| PE Ratio (ttm) | 60.18 |
| Forward PE | 31.89 |
| Analyst | Buy |
| Ask | 83.5 |
| Volume | 2,915,087 |
| Avg. Volume (20D) | 4,005,288 |
| Open | 81.61 |
| Previous Close | 81.01 |
| Day's Range | 79.63 - 82.06 |
| 52-Week Range | 57.52 - 117.27 |
| Beta | 1.46 |
About DXCM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DXCM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DXCM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
DexCom Inc. is scheduled to release its earnings on Jul 24, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-0.23%
Shares of diabetes stocks are trading lower follow...
Unlock content with
Pro Subscription
2 months ago
+0.69%
Dexcom shares are trading higher after the company received FDA clearance for its G7 15-day continuous glucose monitoring system.
